This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rixon, M W Articles by Gelinas, R E Search for Related Content PubMed PubMed Citation Articles by Rixon, M W Articles by Gelinas, R E

 Previous Article  |  Next Article 

Mol Cell Biol. 1988 February; 8(2): 713-721

A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.

Department of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

ABSTRACT

Single base substitutions have been identified in the promoter regions of A gamma-globin genes from individuals with certain types of nondeletion A gamma hereditary persistence of fetal hemoglobin (HPFH). The presence of these mutations is closely associated with the A gamma HPFH phenotype, but proof that they are the nondeletion HPFH determinants is lacking. To test directly whether these base substitutions can result in an increase in A gamma-globin gene transcription, we studied cosmid clones containing the G gamma- through beta-globin gene regions from individuals with Greek-type (G-to-A base substitution at -117) and Chinese-type (C-to-T base substitution at -196) A gamma HPFH in a transient expression assay. When tested as part of a cosmid clone, the Greek HPFH A gamma-globin gene consistently produced about 1.4 times as much RNA as the wild-type A gamma-globin gene when standardized against RNA transcribed from the G gamma genes in cis. The relative strengths of the normal and HPFH A gamma-globin gene promoters were also compared in transient expression assays with plasmids containing the A gamma-globin genes. Pseudo-wild-type A gamma-globin genes containing a short, transcriptionally neutral deletion were used so that two A gamma-globin genes that differed in their promoter sequences could be compared in the same transfection. The plasmid transient expression results indicated a 1.3- to 1.4-fold increase in steady-state RNA levels from the Greek-type A gamma HPFH promoter compared with the wild-type A gamma promoter, while no difference was documented between the Chinese-type A gamma HPFH promoter and the wild-type A gamma promoter.

This article has been cited by other articles:

• Harju-Baker, S., Costa, F. C., Fedosyuk, H., Neades, R., Peterson, K. R. (2008). Silencing of A{gamma}-Globin Gene Expression during Adult Definitive Erythropoiesis Mediated by GATA-1-FOG-1-Mi2 Complex Binding at the -566 GATA Site. Mol. Cell. Biol. 28: 3101-3113 [Abstract] [Full Text]  
• Harju, S., Navas, P. A., Stamatoyannopoulos, G., Peterson, K. R. (2005). Genome Architecture of the Human {beta}-Globin Locus Affects Developmental Regulation of Gene Expression. Mol. Cell. Biol. 25: 8765-8778 [Abstract] [Full Text]  
• Liu, L.-R., Du, Z.-W., Zhao, H.-L., Liu, X.-L., Huang, X.-D., Shen, J., Ju, L.-M., Fang, F.-D., Zhang, J.-W. (2005). T to C Substitution at -175 or -173 of the {gamma}-Globin Promoter Affects GATA-1 and Oct-1 Binding in Vitro Differently but Can Independently Reproduce the Hereditary Persistence of Fetal Hemoglobin Phenotype in Transgenic Mice. J. Biol. Chem. 280: 7452-7459 [Abstract] [Full Text]  
• Navas, P. A., Li, Q., Peterson, K. R., Swank, R. A., Rohde, A., Roy, J., Stamatoyannopoulos, G. (2002). Activation of the {beta}-like globin genes in transgenic mice is dependent on the presence of the {beta}-locus control region. Hum Mol Genet 11: 893-903 [Abstract] [Full Text]  
• Li, Q., Emery, D. W., Fernandez, M., Han, H., Stamatoyannopoulos, G. (1999). Development of Viral Vectors for Gene Therapy of beta -Chain Hemoglobinopathies: Optimization of a gamma -Globin Gene Expression Cassette. Blood 93: 2208-2216 [Abstract] [Full Text]